Skip to main content
Neurology® Neuroimmunology & Neuroinflammation logoLink to Neurology® Neuroimmunology & Neuroinflammation
. 2018 Jun 5;5(4):e473. doi: 10.1212/NXI.0000000000000473

High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies

PMCID: PMC5991775  PMID: 29888300

In the Article “High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies” by C.A. Mecoli et al.,1 the Acknowledgments section should include the following: “CAM was supported by National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases grant T32AR048522.” The authors regret the omission.

Reference

  • 1.Mecoli CA, Lahouti AH, Brodsky RA, Mammen AL, Christopher-Stine L. High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies. Neurol Neuroimmunol Neuroinflamm 2017;4:e381. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology® Neuroimmunology & Neuroinflammation are provided here courtesy of American Academy of Neurology

RESOURCES